Last night, Vancouver’s tech elite were crowded into the Waterfall Building, off Granville Island, enjoying cocktails, tasty vittles and, most importantly, tours of AMPD Ventures’ (AMPD.C) new DC1 high performance computing data centre.
I’ve been to about a decade of Vancouver Resource Investment Conferences, the big Cambridge House BC mining convention that runs every year around this time and, for much of that decade, the mood has been fairly dour.
When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new moves, innovation, maybe some hard austerity decisions.
In this sometimes bizarre microcap world we exist in, we’re often presented with ideas and plans that, at first glance, look like craziness.
New Experion (EXP.V) CEO lays out the real definition of cannabis 2.0… cost controls and common sense
Sick of hearing about how cannabis companies are 'on the cusp of something great' and 'leading the industry'? Well Experion's new CEO has gone another way: Truth.
Cannabis companies take a leaf from the baseball playbook, but sacking CEOs at Supreme (FIRE.T) and Experion (EXP.V) won’t placate the masses
The bodies of cannabis company CEOs are starting float down river. Honey, the CEOs ain't the problem. Name one weed company CEO any other company would hire... I'll wait.
Like the old Twilight Zone episode where helpful aliens leave behind a book called 'To Serve Man', only for us to find out later it's a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they're at the predator's table because they're the main course.
No resource, no multi-million dollar raise, no problem. Ceylon Graphite (CYL.V), which has taken the unusual (in mining circles) decision to just freaking start digging, rather than go through eight years of behind-protection, triangulation, and capital raising first, is up 20% today as the first containers fill with graphite and execs chase down end user agreements. With stock selling for just $0.06 a few days ago, volume has increased and buyers are being found, leading the stock to $0.095 at the time of writing.
With the twitter announcement this morning that Jeanette had "happily" left the position of CEO at Beleave Kannabis (BE.C), Equity.Guru's own Chris Parry was chomping at the bit to find out just what "happily" meant for the market and investors. Twenty minutes after making her announcement, VanderMarel phoned up Chris to give him the skinny on her decision as well as some explanations for past actions which gave both industry players and investors some pause.
Close-ology is a mining term used to describe companies that are close to another company that is running red hot, and may justifiably make the case that they can be hot too. For some, like serial ring-staker Ryan Kalt, close-ology is a business model. The moment someone announces they've found something interesting in Dildo, Newfoundland or Punkydoodle Corners, Ontario, Kalt's crew hops on their laptops, busts out the credit card, and register claims all around it, sometimes without ever having walked the land.
One of the things that pisses a lot of investors off about the resource sector is, the confluence of events most investors are looking for - revenues in and a smaller amount of expenses out - you know, 'actually doing business' - rarely occurs, because so few resource deals ever move into actual production.
If you've been around this joint for a while, you'll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do. That's not because we have a hate on for the dude-bros running the show, or because they're not a client, or because we're short sellers, or any of the other 50 or so reasons MedMen homers have thrown at us over the last few years as a rationale for us not seeing the company in the same rose-coloured way they do. It's because MedMen is, and has always been, shit.